Advertisement
CLS Holdings USA, Inc.

CLS Holdings USA, Inc. Fundamental Analysis

CLSH.CNCNQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.04
$0.010(22.22%)
Canadian Market is Open · 09:48
Advertisement

CLS Holdings USA, Inc. Fundamental Analysis

CLS Holdings USA, Inc. (CLSH.CN) shows moderate financial fundamentals with a PE ratio of -0.49, profit margin of -22.48%, and ROE of 36.74%. The company generates $0.1B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

ROE36.74%
Cash Position19.10%
PEG Ratio0.00

Areas of Concern

Operating Margin-10.00%
Current Ratio0.23
We analyze CLSH.CN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 39.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
39.5/100

We analyze CLSH.CN's fundamental strength across five key dimensions:

Efficiency Score

Weak

CLSH.CN struggles to generate sufficient returns from assets.

ROA > 10%
-56.63%

Valuation Score

Excellent

CLSH.CN trades at attractive valuation levels.

PE < 25
-0.49
PEG Ratio < 2
0.00

Growth Score

Moderate

CLSH.CN shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

CLSH.CN shows balanced financial health with some risks.

Debt/Equity < 1
-0.73
Current Ratio > 1
0.23

Profitability Score

Moderate

CLSH.CN maintains healthy but balanced margins.

ROE > 15%
36.74%
Net Margin ≥ 15%
-22.48%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is CLSH.CN Expensive or Cheap?

P/E Ratio

CLSH.CN trades at -0.49 times earnings. This suggests potential undervaluation.

-0.49

PEG Ratio

When adjusting for growth, CLSH.CN's PEG of 0.00 indicates potential undervaluation.

0.00

Price to Book

The market values CLS Holdings USA, Inc. at -0.19 times its book value. This may indicate undervaluation.

-0.19

EV/EBITDA

Enterprise value stands at -5.76 times EBITDA. This is generally considered low.

-5.76

How Well Does CLSH.CN Make Money?

Net Profit Margin

For every $100 in sales, CLS Holdings USA, Inc. keeps $-22.48 as profit after all expenses.

-22.48%

Operating Margin

Core operations generate -10.00 in profit for every $100 in revenue, before interest and taxes.

-10.00%

ROE

Management delivers $36.74 in profit for every $100 of shareholder equity.

36.74%

ROA

CLS Holdings USA, Inc. generates $-56.63 in profit for every $100 in assets, demonstrating efficient asset deployment.

-56.63%

Following the Money - Real Cash Generation

Operating Cash Flow

CLS Holdings USA, Inc. generates limited operating cash flow of $2.09M, signaling weaker underlying cash strength.

$2.09M

Free Cash Flow

CLS Holdings USA, Inc. produces free cash flow of $1.71M, offering steady but limited capital for shareholder returns and expansion.

$1.71M

FCF Per Share

Each share generates $0.01 in free cash annually.

$0.01

FCF Yield

CLSH.CN converts 11.54% of its market value into free cash.

11.54%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.49

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.19

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.29

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-0.73

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.23

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.37

vs 25 benchmark

ROA

Return on assets percentage

-0.57

vs 25 benchmark

ROCE

Return on capital employed

0.32

vs 25 benchmark

How CLSH.CN Stacks Against Its Sector Peers

MetricCLSH.CN ValueSector AveragePerformance
P/E Ratio-0.4933.74 Better (Cheaper)
ROE36.74%404.00% Weak
Net Margin-22.48%-40219.00% (disorted) Weak
Debt/Equity-0.730.81 Strong (Low Leverage)
Current Ratio0.235.53 Weak Liquidity
ROA-56.63%-281.00% (disorted) Weak

CLSH.CN outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews CLS Holdings USA, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ